|
Match
|
Document |
Document Title |
|
|
US20090226513 |
Na/K-ATpase Ligand
This process relates to a pharmaceutical composition of an Na-K-ATPase ligand which will stimulate Na/K-ATPase signaling in a pharmaceutically acceptable vehicle. In one embodiment, the composition...
|
|
|
US20090088412 |
COMPOSITION FOR TREATING CANCER CELLS AND PREPARATION METHOD THEREOF
A composition for treating cancer cells and a preparation method therefore is provided. The composition includes novel withanolide compounds derived from a Solanaceae plant, which the novel...
|
|
|
US20090036387 |
NOVEL CHEMICAL ENTITIES AFFECTING NEUROBLASTOMA TUMOR-INITIATING CELLS
Disclosed are neuroblastoma tumor-initiating cell inhibiting compositions comprising chemical entities capable of affecting neuroblastoma tumor-initiating cells. Pharmaceutical preparations that...
|
|
|
US20090023666 |
Modulators of Hypoxia Inducible Factor-1 and Related Uses
The invention features compounds of formulas I or II: and pharmaceutically acceptable salts and prodrugs thereof, as well methods for modulating the effects of local and systemic hypoxic events...
|
|
|
US20080255073 |
COMPOUNDS FOR SUSTAINED RELEASE OF ORALLY DELIVERED DRUGS
Disclosed are methods for providing sustained systemic blood concentrations of orally delivered drugs. Still further, disclosed are compounds and pharmaceutical compositions that are used in such...
|
|
|
US20080233189 |
Pharmaceutical Tablets Comprising Two or More Unitary Segments
Accurate means of dosing with a compressed, segmented pharmaceutical tablet, and tablettes formed from said tablets, is disclosed.
|
|
|
US20080188449 |
Treatment of Conditions Caused By Calcium Abnormalities
In certain aspects, the invention relates to use of PKD2 agonists, such as triptolide and triptolide derivatives, to regulate calcium release. In other aspects, the invention relates to use of PKD2...
|